Imatinib in Adult Patients With Metastatic Ocular Melanoma (O-Mel-Inib)

This study has been terminated.
(Study stopped at the end of the first step)
Sponsor:
Collaborators:
Novartis
National Cancer Institute, France
Information provided by (Responsible Party):
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT00421317
First received: January 9, 2007
Last updated: August 10, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)